Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mandeep Bhargava, MD, is a cardiologist in the Section of Cardiac Electrophysiology and Pacing, Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. Dr. Bhargava’s specialty interests are management of atrial fibrillation, supraventricular and ventricular tachycardias, sudden cardiac death, implantable defibrillators and biventricular devices, pacemakers and Wolff-Parkinson-White Syndrome.
Dr. Bhargava received his medical degree from the University of Delhi from Maulana Azad Medical College, where he was honored as “ Best Medical Graduate " and was presented with the R. Vishwanathan Gold Medal by then-Vice President of India, Dr. Shankar Dayal Sharma, PhD. Dr. Bhargava completed a residency in internal medicine followed by a fellowship in cardiology at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. At the completion of his residency, he was named “Best Outgoing Postgraduate Student in Medicine.” He completed his Advanced Fellowship in Cardiac Electrophysiology and Pacing at Cleveland Clinic, Cleveland, OH and also served as the Chief Fellow for the program.
Dr. Bhargava has served as an Assistant Professor of Cardiology at the Postgraduate Institute of Medical Education & Research, Chandigarh, India from 1998 to 2004. Subsequently, he served as an Assistant Professor of Medicine in the Division of Cardiovascular Diseases at the University of Alabama at Birmingham for a year. In 2005, he came back and joined as a member of the Professional Staff at Cleveland Clinic in the Section of Cardiac Pacing and Electrophysiology, Department of Cardiovascular Medicine. He is also an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, Cleveland, OH.
Dr. Bhargava is the author of nine textbook chapters in cardiovascular medicine. He has authored or co-authored more than 35 articles and 75 abstracts in peer-reviewed journals on topics related to cardiac arrhythmia and pacing. He has lectured on his clinical specialty and research at symposia and conferences across the United States, in India and Hong Kong. He has been part of some pioneering work in catheter ablations for atrial fibrillation at the Clinic and continues to have major research interests in atrial fibrillation, ventricular arrhythmias, cardiac resynchronization and defibrillators. Most recently, Dr. Bhargava has also been involved in epicardial ablations and is a Co-Director of an annual training program in this field.
Arrhythmias, Atrial Fibrillation, Long QT Syndrome, Biventricular Pacemaker, Catheter Ablation, Electrophysiology Study, Implantable Cardioverter Defibrillation, Lead Extraction, Pulmonary Vein Isolation Ablation, Ventricular Tachycardia
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/1/2013, Dr. Bhargava has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.